Gladstone Institutional Advisory’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$226K Sell
477
-948
-67% -$477K 0.01% 766
2025
Q4
$665K Sell
1,425
-64
-4% -$29.7K 0.03% 444
2025
Q3
$635K Buy
1,489
+2
+0.1% +$775 0.02% 458
2025
Q2
$570K Sell
1,487
-15
-1% -$5.41K 0.02% 464
2025
Q1
$519K Buy
1,502
+643
+75% +$207K 0.02% 457
2024
Q4
$258K Buy
859
+260
+43% +$90.9K 0.01% 627
2024
Q3
$244K Sell
599
-120
-17% -$43.9K 0.01% 614
2024
Q2
$231K Buy
719
+106
+17% +$34.4K 0.01% 596
2024
Q1
$205K Sell
613
-126
-17% -$38.5K 0.01% 604
2023
Q4
$200K Buy
+739
New +$183K 0.01% 628
2023
Q3
Sell
-739
Closed -$224K 642
2023
Q2
$224K Buy
+739
New +$205K 0.01% 578
2023
Q1
Sell
-850
Closed -$204K 682
2022
Q4
$204K Buy
+850
New +$190K 0.01% 597

Other funds holding HCA

Gladstone Institutional Advisory's HCA Position: Q1 2026 in Review

Gladstone Institutional Advisory reduced its HCA Healthcare (HCA) stake by 67% in Q1 2026, selling an estimated $477K and leaving 477 shares worth $226K. The position accounts for 0.01% of the portfolio, ranked #766.

Gladstone Institutional Advisory first reported a position in HCA in Q4 2022 and has held it in 12 quarters since. The position peaked at $665K in Q4 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Gladstone Institutional Advisory held 477 shares of HCA Healthcare worth $226K as of Q1 2026.
  • Gladstone Institutional Advisory sold 948 HCA Healthcare shares in Q1 2026, an estimated $477K.
  • HCA Healthcare made up 0.01% of Gladstone Institutional Advisory's portfolio in Q1 2026, its #766 holding.
  • Gladstone Institutional Advisory first reported a position in HCA Healthcare in Q4 2022 and has held it in 12 quarters since.
  • Gladstone Institutional Advisory's HCA Healthcare position peaked at $665K in Q4 2025.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q1 2026, filed 14 May 2026.